Galecto (GLTO) Competitors

$0.71
0.00 (0.00%)
(As of 05/7/2024 ET)

GLTO vs. APM, INDP, NRSN, KALA, BIVI, VINC, AVTX, SLGL, TLPH, and ORGS

Should you be buying Galecto stock or one of its competitors? The main competitors of Galecto include Aptorum Group (APM), Indaptus Therapeutics (INDP), NeuroSense Therapeutics (NRSN), KALA BIO (KALA), BioVie (BIVI), Vincerx Pharma (VINC), Avalo Therapeutics (AVTX), Sol-Gel Technologies (SLGL), Talphera (TLPH), and Orgenesis (ORGS). These companies are all part of the "pharmaceutical preparations" industry.

Galecto vs.

Galecto (NASDAQ:GLTO) and Aptorum Group (NASDAQ:APM) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their media sentiment, institutional ownership, profitability, community ranking, dividends, earnings, analyst recommendations, valuation and risk.

Aptorum Group received 11 more outperform votes than Galecto when rated by MarketBeat users. Likewise, 68.33% of users gave Aptorum Group an outperform vote while only 58.82% of users gave Galecto an outperform vote.

CompanyUnderperformOutperform
GalectoOutperform Votes
30
58.82%
Underperform Votes
21
41.18%
Aptorum GroupOutperform Votes
41
68.33%
Underperform Votes
19
31.67%

Galecto currently has a consensus price target of $5.33, indicating a potential upside of 651.17%. Given Galecto's higher possible upside, research analysts plainly believe Galecto is more favorable than Aptorum Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Galecto
0 Sell rating(s)
4 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.20
Aptorum Group
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

In the previous week, Galecto had 3 more articles in the media than Aptorum Group. MarketBeat recorded 3 mentions for Galecto and 0 mentions for Aptorum Group. Galecto's average media sentiment score of 1.22 beat Aptorum Group's score of 0.00 indicating that Galecto is being referred to more favorably in the media.

Company Overall Sentiment
Galecto Positive
Aptorum Group Neutral

Galecto has a beta of 1.26, suggesting that its stock price is 26% more volatile than the S&P 500. Comparatively, Aptorum Group has a beta of 0.85, suggesting that its stock price is 15% less volatile than the S&P 500.

14.2% of Galecto shares are held by institutional investors. Comparatively, 3.8% of Aptorum Group shares are held by institutional investors. 12.1% of Galecto shares are held by company insiders. Comparatively, 64.0% of Aptorum Group shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Aptorum Group's return on equity of 0.00% beat Galecto's return on equity.

Company Net Margins Return on Equity Return on Assets
GalectoN/A -87.11% -68.68%
Aptorum Group N/A N/A N/A

Aptorum Group has higher revenue and earnings than Galecto.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
GalectoN/AN/A-$38.35M-$1.14-0.63
Aptorum Group$430K43.01-$2.83MN/AN/A

Summary

Aptorum Group beats Galecto on 7 of the 13 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding GLTO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

GLTO vs. The Competition

MetricGalectoPharmaceutical IndustryMedical SectorNASDAQ Exchange
Market Cap$19.52M$6.55B$4.93B$7.80B
Dividend YieldN/A2.76%5.29%3.96%
P/E Ratio-0.6311.64130.8715.71
Price / SalesN/A304.822,383.8185.26
Price / CashN/A20.0633.2228.53
Price / Book0.605.754.944.45
Net Income-$38.35M$136.35M$102.40M$214.27M
7 Day Performance4.48%4.96%3.35%3.29%
1 Month Performance-5.28%-3.85%-2.57%-1.47%
1 Year Performance-66.43%4.46%6.24%10.64%

Galecto Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
APM
Aptorum Group
0 of 5 stars
$5.25
+7.6%
N/A+3.2%$18.74M$1.30M0.0018
INDP
Indaptus Therapeutics
2.9731 of 5 stars
$2.17
+2.4%
$12.00
+453.0%
-17.8%$18.53MN/A-1.187Upcoming Earnings
Positive News
NRSN
NeuroSense Therapeutics
0 of 5 stars
$1.35
+4.7%
N/A-26.7%$18.45MN/A-1.6318News Coverage
Gap Up
KALA
KALA BIO
4.1573 of 5 stars
$6.90
+0.7%
$18.00
+160.9%
-54.7%$19.46M$3.89M-0.3843Upcoming Earnings
BIVI
BioVie
1.8314 of 5 stars
$0.49
-2.0%
$8.00
+1,532.7%
-94.0%$19.56MN/A-0.4218Upcoming Earnings
Gap Up
VINC
Vincerx Pharma
1.231 of 5 stars
$0.83
-1.2%
$5.00
+504.6%
-46.2%$17.71MN/A-0.4442Upcoming Earnings
AVTX
Avalo Therapeutics
0 of 5 stars
$17.12
+1.4%
N/A-97.8%$17.63M$1.92M-0.0319Upcoming Earnings
SLGL
Sol-Gel Technologies
3.1066 of 5 stars
$0.71
-18.3%
$8.00
+1,022.8%
-76.9%$19.85M$1.55M-0.7136Upcoming Earnings
Gap Down
TLPH
Talphera
2.3341 of 5 stars
$1.03
+4.0%
$6.00
+482.5%
N/A$17.48M$650,000.00-0.7015Upcoming Earnings
Analyst Forecast
News Coverage
Gap Up
ORGS
Orgenesis
0 of 5 stars
$0.51
+2.0%
N/A-51.9%$17.36M$530,000.00-0.56146Upcoming Earnings
Gap Up

Related Companies and Tools

This page (NASDAQ:GLTO) was last updated on 5/7/2024 by MarketBeat.com Staff

From Our Partners